Castle Biosciences Inc (CSTL)
20.23
+0.72
(+3.69%)
USD |
NASDAQ |
Apr 26, 11:12
Castle Biosciences Profit Margin (Quarterly): -3.90% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -3.90% |
September 30, 2023 | -11.23% |
June 30, 2023 | -37.45% |
March 31, 2023 | -69.47% |
December 31, 2022 | -53.78% |
September 30, 2022 | -54.71% |
June 30, 2022 | -4.73% |
March 31, 2022 | -91.70% |
December 31, 2021 | -25.68% |
September 30, 2021 | -50.23% |
June 30, 2021 | -38.63% |
March 31, 2021 | -18.76% |
Date | Value |
---|---|
December 31, 2020 | -28.26% |
September 30, 2020 | -30.16% |
June 30, 2020 | -10.82% |
March 31, 2020 | 3.27% |
December 31, 2019 | 11.65% |
September 30, 2019 | 39.59% |
June 30, 2019 | -11.82% |
March 31, 2019 | -15.58% |
December 31, 2018 | 33.83% |
September 30, 2018 | -92.95% |
June 30, 2018 | -79.28% |
March 31, 2018 | -99.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-91.70%
Minimum
Mar 2022
39.59%
Maximum
Sep 2019
-25.62%
Average
-25.68%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
Exact Sciences Corp | -7.69% |
Illumina Inc | -15.60% |
Mettler-Toledo International Inc | 19.76% |
Waters Corp | 26.38% |
Natera Inc | -25.08% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -14.81% |
Return on Assets | -13.13% |
Return on Invested Capital | -14.81% |
Gross Profit Margin (Quarterly) | 81.21% |
Operating Margin (Quarterly) | -8.56% |
Return on Net Operating Assets | -30.08% |